FDA extends review of J&J, Legend’s cell therapy for multiple myeloma
Abecma and cilta cel are part of an emerging class of multiple myeloma treatments that target a protein called BCMA, which is found on cancer cells. GlaxoSmithKline w...
Continue Reading →
